When considering new policy that improves human health and well-being, regulators and industry are often able to estimate the costs of more stringent environmental policies, such as increased costs for regulated industries, higher costs of consumer products and higher administrative burden for regulators. It is equally important to weigh these costs against the economic benefits of the policy, such as improved health and reduced mortality.
The value of statistical life (VSL) is an increasingly common part of cost-benefit analyses that can be used to quantify the economic benefits of reduced mortality in a range of policy-relevant applications such as air quality improvements, traffic safety and health policy.